GLOBUS MEDICAL INCGMED

Market cap
$12.3B
P/E ratio
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income746992113104107156155102149190123103
Acquired in-process research and development------------13
Depreciation and amortization1819222439424253637068145254
Amortization of premiums on marketable securities-------1-1-3-5-11
Inventory Write-down68710131210218661123
Amortization of inventory fair value step up-----------72215
Amortization Of Note Fair Value Step Up-----------827
Share-based Compensation55710111522262731335354
Provision for Doubtful Accounts0101121331-0417
Change in fair value of business acquisition liabilities----311231751727
Change in deferred income taxes-6-15-46-4814-4-18-22-58-126
(Gain)/loss on disposal of assets, net------4-1-1-0-0-2-6
Payment of business acquisition-related liabilities---------03319
Net (gain)/loss from foreign currency adjustment------------1425
Accounts receivable7101345252218-1126515078
Inventories2117181911531505012627030
Prepaid expenses and other assets0101-5571211610-1-1
Accounts payable325-4-010-31-6414-1418
Accrued expenses and other liabilities4274-6-18-215718186175
Income taxes payable/receivable-24-5-17-4-1-125-3-0-13
Net cash provided by/(used in) operating activities779379122172160182172199276178243521
Purchases of marketable securities-241251298287393538347224622420101114
Maturities of marketable securities-4118518928224027824713422831224059
Sales of marketable securities---------11010253812
Purchases of property and equipment252425514151607164577478115
Acquisition of businesses, net of cash acquired and purchases of intangible and other assets61736497630152433343129618
Net cash provided by/(used in) investing activities-31-227-100-151-100-111-193-140-117-376-110303-176
Payment of business acquisition-related liabilities111151077697846
Proceeds from Stock Options Exercised---5612393172634212110
Payments related to tax withholdings for share-based compensation-----------117
Repurchase of common stock--------105-14422686
Net cash provided by/(used in) financing activities2411136223324-3954-110-232-28
Effect of foreign exchange rates on cash--------1-1-120
Net increase/(decrease) in cash and cash equivalents------21-44-46-43317317
Income Taxes Paid--------254578101159
Stock Issued-----------2,154-
Accrued purchases of property and equipment--------45779